Device Trial Radar · NCT07938112
Efficacy and Safety of Electroacupuncture in the Treatment of Esophageal Symptoms in Non-erosive Reflux Disease (NERD) Patients
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
96
Planned (sponsor's estimate)
Start
Nov 2026
Primary completion
Dec 2027
Study completion Mar 2028
Sponsor
- Lead sponsor
- Nanyang Technological UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National University Hospital, Singapore
- First posted
- Nov 16, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 21 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if acupuncture works to treat non-erosive reflux disease (NERD) patients. The main questions it aims to answer are: 1. Electroacupuncture (EA) is superior to sham EA in terms of easing the symptom severity of NERD. 2. Acupuncture is able to influence gastrointestinal function, autonomic regulation, and stress responses in NERD patients. Participants will: 1. Receive acupuncture treatment twice per week for 6 weeks. 2. Leave plasma, serum, saliva, stool, and urine samples at baseline, mid-treatment, and end-of-treatment. 3. Complete patient-reported-outcomes (PROs) at baseline, mid-treatment, and end-of-treatment
Conditions
- Non-erosive Reflux Disease (NERD)
Interventions
Acupuncture needlesDevice
The acupuncture needles and related equipment will have already received approval for routine Traditional Chinese Medicine (TCM) clinical practice in Singapore.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Gastroesophageal Reflux Disease Questionnaire (GERDQ)Time frame: From enrollment to the end of follow-up at 16 weeks
- Gastrointestinal Symptom Rating scale (GSRS)Time frame: From enrollment to the end of follow-up at 16 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nanyang Technological University, School of Biological Sciences
Singapore, Singapore
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.